1. TNT post hoc analysis: Improvement between baseline and final visit in estimated GFR by treatment group
End point
10-mg atorvastatin
80-mg atorvastatin p
eGFR (MDRD), % increase
5.6
8.4
<0.0001
Shepherd J et al. American College of Cardiology 2006 Scientific Sessions; March 13, 2006; Atlanta, GA. Abstract 808-3

2. TNT post hoc analysis: Patients with improvement or decline from baseline eGFR by treatment group
Measure
10-mg atorvastatin
80-mg atorvastatin p
Patients with improvement in GFR from <60 mL/min per 1.73m2 (%) 37 45
0.0004
Patients with decline in eGFR from >60 mL/min per 1.73m2 (%) 9 7
<0.001
Shepherd J et al. American College of Cardiology 2006 Scientific Sessions; March 13, 2006; Atlanta, GA. Abstract 808-3